| Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis F Alrashed, R Battat, I Abdullah, A Charabaty, M Shehab BMJ open gastroenterology 8 (1), e000774, 2021 | 16 | 2021 |
| Relationship between patient sex and serum tumor necrosis factor antagonist drug and anti-drug antibody concentrations in inflammatory bowel disease; a nationwide cohort study M Shehab, H Alasfour, I Abdullah, G Alhendi, A Alhadab, A Alfadhli, ... Frontiers in Medicine 8, 801532, 2021 | 9 | 2021 |
| Population perceptions of health care services provided virtually (telehealth): a cross-sectional study R AlMatar, A Al-Haqan, I Abdullah, S Waheedi Journal of Public Health 45 (2), 505-512, 2023 | 5 | 2023 |
| Exploring healthcare providers’ perspectives on virtual care delivery: insights into telemedicine services IK Abdelghany, R AlMatar, A Al-Haqan, I Abdullah, S Waheedi BMC Health Services Research 24 (1), 1, 2024 | 2 | 2024 |
| Effectiveness of vedolizumab and ustekinumab as second biologic agent in achieving target outcomes in tumor necrosis factor antagonists experienced patients with inflammatory … F Alrashed, I Abdullah, A Alfadhli, M Shehab Frontiers in Pharmacology 14, 1243080, 2023 | 1 | 2023 |
| Effectiveness of Dual Biologic or Small Molecule Therapy for Achieving Endoscopic Remission in Refractory Inflammatory Bowel Disease I Abdullah, K AlMojil, M Shehab Diseases 10 (4), 102, 2022 | 1 | 2022 |
| Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-Term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective Study M Shehab, F Alrashed, I Abdullah, A Alfadhli, H Ali, M Abu-Farha, ... Frontiers in Medicine 9, 881027, 2022 | 1 | 2022 |
| P184 Relationship Between Patient Sex and Serum Tumor Necrosis Factor Antagonist Drug and Anti-Drug Antibody Concentrations in Inflammatory Bowel Disease; A Nationwide Cohort Study M Shehab, H Alasfour, I Abdullah, G Alhendi, A Alhadab, A Alfadhli, ... Journal of Crohn's and Colitis 16 (Supplement_1), i249-i250, 2022 | 1 | 2022 |
| P794 Relationship between Ustekinumab Trough Concentrations and Clinical, Biochemical and Endoscopic Outcomes in Crohn’s Disease; A Multi-Center Nationwide Study (TARGET STUDY) M Shehab, F Alrashed, I Abdullah, A Alfadhli Journal of Crohn's and Colitis 18 (Supplement_1), i1483-i1483, 2024 | | 2024 |
| Impact of tumor necrosis factor antagonist combination and anti-integrin therapies on body mass index in inflammatory bowel disease: A cross-sectional study M Shehab, A Alali, A Al-Hindawi, A Alsayegh, U Aldallal, I Abdullah, ... Frontiers in Medicine 9, 1045661, 2023 | | 2023 |
| S872 Association Between Medical Therapies for Inflammatory Bowel Disease and Severe COVID-19: A Systematic Review and Meta-Analysis F Alrashed, I Abdullah, M Shehab Official journal of the American College of Gastroenterology| ACG 116, S408, 2021 | | 2021 |
| Gastroenterologists Adherence to Tumor Necrosis Factor Antagonist Combination Therapy in Inflammatory Bowel Disease I Abdullah, G Alhendi, A Alhadab, H Alasfour, M Shehab Frontiers in Medicine 8, 725512, 2021 | | 2021 |
| Association Between Medical Therapies for Inflammatory Bowel Disease and Severe COVID-19: A Systematic Review and Meta-Analysis F Alrashed, I Abdullah The American Journal of Gastroenterology, 2021 | | 2021 |
